Kimiteru Ito Selected Research

2- oxo- 1,2,3,6- tetrahydropyrimidine- 4,6- dicarboxylate

1/2021

Initial Experience of Intentional Internal High-Dose Policy Volumetric Modulated Arc Therapy of Neck Lymph Node Metastases ≥ 2 cm in Patients With Head and Neck Squamous Cell Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kimiteru Ito Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 08/2008
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 01/2017
4	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 04/2008
4	Sarcoidosis (Schaumann Disease) 04/2014 - 02/2013
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
3	Squamous Cell Carcinoma of Head and Neck 01/2021 - 02/2014
3	Cognitive Dysfunction 12/2015 - 11/2011
3	Alzheimer Disease (Alzheimer's Disease) 12/2015 - 11/2011
3	Lymphoma (Lymphomas) 07/2011 - 11/2010
2	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2020
2	Dementia (Dementias) 12/2015 - 12/2013
2	Brain Neoplasms (Brain Tumor) 01/2015 - 03/2012
2	Head and Neck Neoplasms (Head and Neck Cancer) 02/2014 - 07/2010
2	Infections 05/2013 - 08/2010
2	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2011 - 12/2010
1	Retinoblastoma (Glioblastoma, Retinal) 01/2022
1	Mediastinal Cyst 01/2022
1	Thymoma (Thymic Carcinoma) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2021
1	Nasopharyngeal Carcinoma 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Cholangitis 01/2021
1	Cough 01/2021
1	Lymphatic Metastasis 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Radiation Pneumonitis 01/2021
1	Acquired Hyperostosis Syndrome (SAPHO Syndrome) 01/2021
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Parkinsonian Disorders (Parkinsonism) 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2016
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2015
1	Multiple Myeloma 04/2015
1	Necrosis 01/2015
1	Classical Lissencephalies and Subcortical Band Heterotopias 08/2014
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2014
1	Muscle Weakness 12/2013
1	Granuloma 08/2013
1	Muscle Hypotonia (Hypotonia) 06/2013
1	Allan-Herndon-Dudley syndrome 06/2013
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 05/2013
1	Hypoalbuminemia 05/2013
1	Cysts 04/2013
1	Amyloid Plaque 08/2012
1	Gouty Arthritis 06/2012

Drug/Important Bio-Agent (IBA)

22	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 09/2009
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
3	IronIBA 01/2017 - 07/2011
2	pembrolizumabIBA 01/2022 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 12/2021 - 09/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2020
2	Estrogen ReceptorsIBA 01/2021 - 09/2020
2	human ERBB2 proteinIBA 01/2021 - 09/2020
2	SteroidsIBA 01/2021 - 06/2011
2	SolutionsIBA 01/2021 - 01/2016
2	IpilimumabIBA 04/2019 - 01/2019
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 12/2015 - 08/2012
2	technetium Tc 99m bicisate (Neurolite)FDA Link 08/2014 - 06/2013
2	Glucose (Dextrose)FDA LinkGeneric 08/2013 - 11/2011
2	Heparin (Liquaemin)FDA LinkGeneric 02/2013 - 05/2011
2	Choline (Choline Chloride)IBA 02/2011 - 11/2010
1	NivolumabIBA 01/2022
1	durvalumabIBA 01/2021
1	2- oxo- 1,2,3,6- tetrahydropyrimidine- 4,6- dicarboxylateIBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	AntigensIBA 12/2020
1	Gallium-68IBA 12/2020
1	Glycoproteins (Glycoprotein)IBA 12/2020
1	gallium 68 PSMA-11IBA 12/2020
1	MucinsIBA 06/2020
1	Epithelial Cell Adhesion MoleculeIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Amino Acids FDA Link 04/2015
1	DNA (Deoxyribonucleic Acid)IBA 04/2015
1	methionine methyl esterIBA 01/2015
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2014
1	Myeloblastin (Proteinase 3)IBA 01/2014
1	Nonesterified Fatty Acids (NEFA)IBA 01/2014
1	Amyloid (Amyloid Fibrils)IBA 12/2013
1	Thyroid HormonesIBA 06/2013
1	AlbuminsIBA 05/2013
1	Proteins (Proteins, Gene)FDA Link 05/2013
1	tributyl phosphate (TBP)IBA 04/2013

Therapy/Procedure

12	Therapeutics 01/2022 - 07/2010
8	Radiotherapy 01/2021 - 07/2010
6	Drug Therapy (Chemotherapy) 04/2019 - 07/2010
5	Immunotherapy 01/2022 - 04/2019
4	Brachytherapy 01/2022 - 04/2008
1	Intraperitoneal Injections 09/2021
1	Self Expandable Metallic Stents 01/2021
1	Choledochostomy 01/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021
1	Induction Chemotherapy 01/2021
1	Precision Medicine 12/2020
1	Aftercare (After-Treatment) 01/2019
1	Activities of Daily Living (ADL) 01/2017